AngioDynamics Reports Fiscal 2017 Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
AngioDynamics (ANGO) Tops Q2 EPS by 21c; Guides Roughly In-Line
January 6, 2017 6:06 AM ESTAngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.37, $0.21 better than the analyst estimate of $0.16. Revenue for the quarter came in at $89 million versus the consensus estimate of $91.09 million.
GUIDANCE:
AngioDynamics sees FY2017 EPS of $0.65-$0.67, versus the consensus of $0.66. AngioDynamics sees... More
